Wednesday, April 8, 2026

AMC: Analysts Call For EPS Of -$0.19 In Q2

AMC Entertainment Holdings, Inc. (NYSE: AMC) will report its second quarter financial results on August 4th after market close. Analysts have a consensus $9.09 12-month price target on the company, via a total of 8 analysts, with 3 analysts having hold ratings, 3 analysts have sell ratings and the last 2 analysts have strong sell ratings on the stock.

Seven analysts have revenue estimates for the second quarter. The mean revenue estimate between all seven analysts is $1.18 billion; this number has been revised downwards from $1.25 billion at the start of the year. The highest revenue estimate is $1.28 billion, while the lowest is $1.1 billion.

Onto EBITDA estimates, there are currently seven analysts who have second quarter EBITDA estimates. The mean is currently $78.9 million, with this number having been revised downwards from $148 million at the start of the year. Street high is a $126.6 million EBITDA estimate and the lowest is $15.9 million.

Analysts estimate that quarterly earnings per share will come in at -$0.19, with this number being revised downwards from -$0.11 at the start of the year. The street high estimate is -$0.09 and the lowest estimate is -$0.36 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why the Market May Be Misreading Iran | David Woo

Why US Fertilizer Supply Could Matter a Lot More Now | Pat Varas – Sage Potash

Roscan Gold: Mali Discount Hits Kandiole PEA

Recommended

Canadian Gold Drills 19.5 g/t Gold Over 1.0 Metre At Lac Arsenault

Canadian Copper Secures Key Approval for Caribou Complex Acquisition

Related News

MediPharm Labs: Canaccord Slashes Price Target Following Q4 Results

Earlier this week, Medipharm Labs (TSX: LABS) reported their fourth quarter and 2020 year-end financial...

Friday, April 2, 2021, 09:00:00 AM

Haywood Initiates Coverage On Ascend Wellness With $16.50 Price Target

Haywood Capital Markets recently became the latest firm to initiate coverage on Ascend Wellness (CSE:...

Wednesday, September 1, 2021, 03:33:00 PM

Canopy Growth Sees Cantor Lower Price Target To $21

Last week, Cantor Fitzgerald updated their estimates on a bundle of Canadian licensed producers. In...

Friday, September 24, 2021, 03:33:00 PM

Cresco Labs: PI Financial Reiterates $23 Price Target Following Q1 Financials

Cresco Labs (CSE: CL) reported its first-quarter financial results last night. The company announced revenue...

Thursday, May 27, 2021, 05:04:00 PM

SNDL: Canaccord Reiterates Ratings Following Superette Transaction

On August 31, SNDL Inc (NASDAQ: SNDL) announced that they agreed to acquire all of...

Sunday, September 4, 2022, 11:04:00 AM